![]() | Only 14 pages are availabe for public view |
Abstract Vitiligo is an acquired depigmenting muco-cutaneous disorder characterized by melanocytes loss. Its universal incidence ranges from 0.5% to 2% of population without any racial or sexual differences. Vitiliginous patches contain either reduced or absent melanin. The patches are initially small but they progressively enlarge and coalesce giving large patches. Many hypotheses have been supposed to explain the mechanism of melanocytes destruction, including autoimmune mechanisms, cytotoxic mechanisms, an intrinsic defect of melanocytes,oxidant–antioxidant mechanisms, melanocytorrhagy and neural mechanisms. Cold-inducible RNA-binding protein (CIRP), also called CIRBP or A18 hnRNP, it is a member of the cold shock protein family. It is a glycine-rich RNA chaperone that facilitates RNA translation. Cold-inducible RNA-binding protein (CIRP) has been defined as an inflammatory mediator and a damage-associated molecular pattern (DAMP), which is highly expressed during trauma and shock. It can induce a variety of cellular responses including the release of proinflammatory cytokines and endothelial dysfunction. The current study aimed to shed light on the possible role of CIRP in the pathogenesis of vitiligo through evaluation of CIRP tissue and serum levels, in addition to correlate the evaluated results with the clinical aspects of vitiligo in those patients. Recent studies reported that CIRP p‟ay its role through binding to the TLR4/MD2 complex on both CD8+ and CD4+ T-cells to induce Summary 91 their activation and stimulates the release of TNF-α and HMGB1 from antigen-presenting cells. This study aimed to evaluate the expression of CIRP, (serum and tissue), in vitiligo cases and to correlate this expression to the clinico-pathological data of the patients. This case-control study included twenty patients presented with vitiligo. They were selected from Outpatient Clinic, Dermatology, Andrology and STDs Department, Faculty of Medicine, Menoufia University and twenty age and sex matched healthy subjects as a control group who attending Plastic Surgery OutpatientClinic, Menoufia University. Exclusion Criteria included dermatological diseases other than vitiligo, history of malignancy, inflammatory diseases or symptoms of any infections. A written consent was obtained all patients were subjected to complete history taking, dermatological examination and registration of VAsIscore. 3 millileters of venous blood samples were taken under complete aseptic conditions from every participant.The samples centrifuged for 10 min at 4000 r.p.m.. The serum obtained for assessment of serum CIRP by ELISA technique. Skin biopsies were taken under local anaesthesia from all cases (lesions) and controls for histopathological and immunohistochemical evaluation using H&E and CIRP antibody stains. In the current study, Positive expression of Cold inducible RNA protein (CIRP) was observed in all cases (20 cases 100%) in lesional and prelesional tissue in addition to control group (20 cases 100%) with nuclear localization in all of the stained cells. Summary 92 A significant difference in CIRP epidermal expression between lesional, perilesional cases and controls was observed. It was high in cases lesional and perilesional epidermis. There was a highly significant difference between cases and controls regarding mean serum cold inducible RNA binding protein level, as it was higher in cases than controls (P value <0.001) There was significant positive correlation between serum cold inducible RNA protein and VASI score among the studied cases (P value 0.013). There was no significant relation between H score of lesional epidermis and histo-pathological data of the studied cases was found. No significant relation between serum cold inducible RNA binding protein and clinical data of the studied cases except for family history, cases with positive family history had higher serum level of CIRP (318.2±48.0) than cases with negative history (254.0±20.6), (p=0.005).So we recommend Further large scaled studies to validate our results. |